Clinical Trial Update: Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating 16α-[18F]Fluoro-17β-estradiol PET imaging correlation with ESR1 mutation in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN